(Press-News.org) Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth. When cancer cells begin to die within tumors, they expose signals on their surface that indicate they are dying. Macrophages then detect these signals and engage in phagocytosis, where they eat dying cancer cells. Using fruit flies as a model organism, the scientists found this triggers production of proteins called cytokines, which activate growth signals in remaining cancer cells. These cells then produce more cytokines, causing an unexpected chain reaction that promotes tumor growth.
The study, published in the journal Current Biology, showed that blocking any part of this pathway, whether preventing the macrophages from eating dying cancer cells or stopping cytokine production, significantly reduced tumor growth. (Watch a macrophage eating a cancer cell here. Credit: Hirooka et al., 2025)
Good cells gone bad
When macrophages in fruit flies consume dying cancer cells, they produce an inflammatory cytokine called Upd3, a protein similar to human IL-6. This Upd3 activates JAK and STAT proteins inside living cancer cells. These proteins normally coordinate immune responses and tissue repair, but cancer cells hijack this process: They turn on genes that make them produce their own Upd3, enhancing JAK and STAT activation and promoting tumor growth.
“We used genetically modified fruit flies to study cancer because their immune system is similar to ours, and they offer a powerful model system for research in the laboratory. We created tiny tumors in their eye tissue and used fluorescent markers to track cancer cells and macrophages in real-time under microscopes,” Eri Hirooka, a PhD student at the Graduate School of Science at Nagoya University and lead author, explained.
To understand how these cells interact, the researchers turned genes on and off, added or removed specific proteins, and measured the effects on tumor growth. They observed macrophages consuming dying cancer cells and measured the cytokine signals being produced during this process.
When they genetically decreased the macrophages’ ability to eat dying cancer cells or decreased Upd3 production, tumor growth was significantly reduced. The results challenge the assumption that enhancing immune cell phagocytosis is always beneficial in cancer treatment—many therapies aim to boost immune cell activity, but this research shows that could backfire.
From flies to humans: Broader implications
The study shows that cancer cells are more cunning than expected. Instead of just receiving growth signals from immune cells, they actively boost those signals by producing their own Upd3. This mechanism may be universal across species because the dying cancer cells that start the whole process are commonly found in tumors, especially in advanced cancers.
Senior author Professor Shizue Ohsawa from Nagoya University’s Department of Biological Science noted that targeting this interaction between macrophages and dying cancer cells could be a new way to treat cancer in humans: “Because the molecular pathways between fruit flies and humans are evolutionarily preserved, understanding these mechanisms could explain why some cancers with high cell death rates can still grow aggressively and lead to improved treatments.”
The study, “Macrophages promote tumor growth by phagocytosis-mediated cytokine amplification in Drosophila,” was published in the journal Current Biology, on June 25, 2025, at DOI: 10.1016/j.cub.2025.05.068.
END
Immune cells promoting tumor growth? How dying cancer cells turn their enemies into allies
An inflammatory feedback loop helps cancer hijack immune responses to spread tumors.
2025-06-25
ELSE PRESS RELEASES FROM THIS DATE:
How diverse brain cells reach a decision together
2025-06-25
Every decision begins invisibly.
Long before someone acts, the brain is already hard at work gathering evidence, weighing options, and gradually committing to a choice. But even when faced with the same evidence, people can arrive at different outcomes, especially when the decision is difficult. Two different drivers in rush hour traffic, for example, see the same congested road, yet one might speed up to merge while another cautiously brakes.
How the brain, made up of billions of specialized cells, makes ...
Pervasive surveillance of people is being used to access, monetize, coerce, and control
2025-06-25
New research has underlined the surprising extent to which pervasive surveillance of people and their habits is powered by computer vision research – and shone a spotlight on how vulnerable individuals and communities are at risk.
Analyses of over 40,000 documents, computer vision (CV) papers and downstream patents spanning four decades has shown a five-fold increase in the number of computer vision papers linked to downstream surveillance patents. The work also highlights the rise of obfuscating language that is used to normalise and even hide the existence of surveillance.
The research, ...
New global index aims to help people and nature thrive together
2025-06-25
EMBARGOED UNTIL JUNE 25TH 16:00 UK TIME
New Global Index Aims to Help People and Nature Thrive Together
Researchers at Oxford University join the United Nations Development Programme to propose an optimistic, practical approach to inspire stronger action on nature.
Oxford, 25 June 2025 — As the world faces an escalating planetary crisis, a new paper published today in Nature offers something we don’t often hear - hope. Rather than focussing on what we’re doing wrong, the paper proposes a bold new way forward; a global framework that measures how well people and nature are thriving together.
The ...
Increased prescribing of ADHD medication and real-world outcomes over time
2025-06-25
About The Study: In this study, attention-deficit/hyperactivity disorder (ADHD) medication remained associated with reduced risks of several serious real-world outcomes (self-harm, unintentional injury, traffic crashes, and crime). However, the magnitude of these associations appears to have decreased alongside rising prescription rates over time. Thus, it is important to regularly evaluate medication use in different patient populations.
Corresponding Authors: To contact the corresponding authors, email Zheng Chang, PhD, (zheng.chang@ki.se) ...
New study shows how biomass changed over 500 million years
2025-06-25
In a first-of-its-kind study, Stanford researchers have measured how the abundance of ocean life has changed over the past half-billion years of Earth’s history.
Overall, the total mass of marine organisms has generally increased over the past 500 million years, the study showed, albeit with setbacks after major extinction events. The findings align with evidence for a similar rise in marine biodiversity – the total variety of organisms – over the past half-eon from studies dating as far back as the 19th century, suggesting an evolutionary connection between biomass and biodiversity. ...
Estimated 2023-2024 COVID-19 vaccine effectiveness in adults
2025-06-25
About The Study: In this case-control study of vaccine effectiveness, 2023-2024 COVID-19 vaccines were estimated to provide additional effectiveness against medically attended COVID-19, with the highest and most sustained estimates against critical illness. These results highlight the importance of receiving recommended COVID-19 vaccination for adults 18 years or older.
Corresponding Author: To contact the corresponding author, Ruth Link-Gelles, PhD, MPH, email hzt7@cdc.gov.
To access the embargoed study: Visit our For The Media website at this link ...
City of Hope’s Dr. Yuman Fong delivers Lister Legacy Lecture, spotlighting surgical cancer innovations
2025-06-25
LOS ANGELES — Yuman Fong, M.D., chair of the Department of Surgery at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named a Top 5 “Best Hospital” in the nation for cancer care by U.S. News & World Report, this month delivered the Lister Legacy Lecture at the triennial conference of The Royal College of Surgeons of Edinburgh. This presentation honors the long-term impact of Baron Joseph Lister, M.D., who brought antiseptic ...
Creation of new molecule could help develop stamp-sized hard drives capable of storing 100 times more data than current tech
2025-06-25
Chemists from The University of Manchester and The Australian National University (ANU) have engineered a new type of molecule that can store information at temperatures as cold as the dark side of the moon at night, with major implications for the future of data storage technologies.
The findings, published in Nature, could pave the way for next-generation hardware about the size of a postage stamp that can store 100 times more digital data than current technologies.
“The ...
COVID vaccine reduces severity of illness, death for adults, especially among at-risk populations
2025-06-25
A new multi-state study led by the Centers for Disease Control and Prevention’s (CDC) VISION Network – including Regenstrief Institute – has provided the most comprehensive assessment to date of the effectiveness of 2023-2024 COVID-19 vaccines among adults in the U.S. during the XBB and JN.1 Omicron subvariant waves.
Data suggest that receiving updated COVID-19 vaccines remains crucial, especially for older adults and those at increased risk for severe outcomes, and underscores the additional protection provided ...
Can targeted payment adjustments help solve the infectious disease physician shortage?
2025-06-25
Key Points:
Infectious disease (ID) physicians are among the lowest paid of all medical specialties, leading to declining interest among medical students and a national shortage.
To address this, the Centers for Medicare and Medicaid Services (CMS) introduced a new add-on code increasing payments by ~20% in 2025, the first specialty-specific workforce incentive in the Medicare fee schedule.
This new analysis offers three recommendations for CMS to guide implementation and evaluation of this new payment model.
Boston, MA – A new analysis ...
LAST 30 PRESS RELEASES:
The Lancet: Tens of thousands of children aged under five suffering acute malnutrition in Gaza, recent estimates suggest
Prostate testing may not target those most likely to benefit, warn experts
Global analysis shows hidden damage from men’s alcohol use
DRI recognizes Ashley Cornish as the 2025 Peter B. Wagner Memorial Award Winner for Women in Atmospheric Sciences
Unlocking the blueprint for a powerful plant-based drug
Bringing modern science to vitamin biology: Isha Jain wins NIH Transformative Research Award
University of Houston scientists learn that rare bacterium ‘plays dead’ to survive
Introduced animals change how island plants spread, new global study finds
Mayo Clinic researchers discover ‘traffic controller’ protein that protects DNA, and may help kill cancer cells
Protein sidekick exhibits dual roles in stress granule assembly and disassembly
New hope for MS
Kennesaw State professor receives grant to study cancer origins
Pain and antidepressant drug combo linked to increased seizure risk in older adults
Cancer researchers shape new strategies for immunotherapy
Physical exercise can ‘train’ the immune system
Calm red brocket deer can learn to "Come" and other commands - but the flightiest, most restless individuals struggle
China, the world's largest tea producer, is predicted to experience increases in land suitable for tea-growing under climate change, with the overall range shifting northwards, per AI modeling study
Composing crews for Mars missions
Early humans butchered elephants using small tools and made big tools from their bones
1,000-year-old gut microbiome revealed for young man who lived in pre-Hispanic Mexico
Bears and pandas in captivity develop significantly different gut microbiomes compared to their wild counterparts, and giant pandas in particular have less diverse microbiomes than their wild counterp
Prenatal and postnatal support apps might not work
Dancing dust devils trace raging winds on Mars
Raging winds on Mars
Real-time biopsies uncover hidden response to glioblastoma therapy
Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma
Novel immunotherapy combination destroys colorectal liver metastases
Farmed totoaba could curb poaching
Avalanches: user-carried safety device increases survival time fivefold
It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain
[Press-News.org] Immune cells promoting tumor growth? How dying cancer cells turn their enemies into alliesAn inflammatory feedback loop helps cancer hijack immune responses to spread tumors.